Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Samir Seleq und 2 weiteren Autor:innen. Beteiligte Einrichtung: Waikato District Health Board, Hamilton, Waikato, New Zealand. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Inflammatory bowel disease (IBD) prevalence is rising globally; however, indigenous groups are underrepresented. Waikato, New Zealand, is a large region with a high proportion of Māori patients. In Canterbury in 2006, 1% of patients with IBD were Māori. We investigated the incidence and prevalence of IBD in Waikato over 10 years.
Methods
This was a retrospective cohort study assessing the incidence and prevalence of IBD between 2009 and 2019. The search strategy included pathology, radiology, Provation, ICD‐10 coding and private clinics, using the keywords: Crohn's, Crohn, ileitis, colitis, ulcerative, inflammatory bowel disease and IBD. Collected data included current age and age at diagnosis, sex, ethnicity and IBD subtype.
Results
The IBD point prevalence on 31 December 2019 was 375.6/100 000 compared with 293.6/100 000 in 2010, increasing by 27.9%. The annualised incidence was static from 21.5/100 000 in 2010 to 17.5/100 000 in 2019. Female patients comprised 53.3% of the cohort. Ulcerative colitis (UC) made up 54.2% of cases, 43.8% had Crohn disease (CD) and 2.0% had indeterminate colitis. Sixty (3.7%) patients identified as Māori. In non‐Māori patients, the average age at diagnosis was 36.2 years, compared with 33.0 years in Māori patients ( P = 0.11). In Māori patients, 53.3% had UC and 45.0% had CD. Thirty‐five percent of Māori patients lived 50 km or more from base hospital, compared with 41% of non‐Māori patients ( P = 0.33).
Conclusion
IBD prevalence has increased substantially; however, the incidence has remained static. Māori IBD rates are higher than previously reported, in keeping with international indigenous trends. Māori patients were diagnosed at a similar age as non‐Māori patients, with similar disease subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Waikato District Health Board, Hamilton, Waikato, New Zealand.
ORCID-Profile: Samir Seleq, James Fulforth
Zitieren
APA
Seleq, S., Weilert, F., & Fulforth, J. (2023). Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence. Internal Medicine Journal. https://doi.org/10.1111/imj.16072
Vancouver
Seleq S, Weilert F, Fulforth J. Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence. Internal Medicine Journal. 2023. doi:10.1111/imj.16072
BibTeX
@article{Seleq2023,
author = {Seleq, Samir and Weilert, Frank and Fulforth, James},
title = {Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16072}
}
EUVIMED